CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 5895-5903

  Sutavani, Ruhcha V ^a   Bradley, Richard G ^a   Ramage, Judith M ^a   Jackson, Andrew M ^a   Durrant, Lindy G ^a   Spendlove, Ian ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CD28 ANTIGEN; CD97 ANTIGEN; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MOLECULAR INTERACTION; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84890391485     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301458     Document Type: Article

References (52)

1. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
2. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50.
3. Bergmann, C., L. Strauss, Y. Wang, M. J. Szczepanski, S. Lang, J. T. Johnson, and T. L. Whiteside. 2008. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Clin. Cancer Res. 14: 3706-3715.
4. Gagliani, N., T. Jofra, A. Stabilini, A. Valle, M. Atkinson, M. G. Roncarolo, and M. Battaglia. 2010. Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes 59: 433-439.
5. Huurman, V. A., J. H. Velthuis, R. Hilbrands, T. I. Tree, P. Gillard, P. M. van der Meer-Prins, G. Duinkerken, G. G. Pinkse, B. Keymeulen, D. L. Roelen, et al. 2009. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am. J. Transplant. 9: 382-388.
6. VanBuskirk, A. M., W. J. Burlingham, E. Jankowska-Gan, T. Chin, S. Kusaka, F. Geissler, R. P. Pelletier, and C. G. Orosz. 2000. Human allograft acceptance is associated with immune regulation. J. Clin. Invest. 106: 145-155.
7. Battaglia, M., S. Gregori, R. Bacchetta, and M. G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18: 120-127.
8. Gagliani, N., C. F. Magnani, S. Huber, M. E. Gianolini, M. Pala, P. Licona-Limon, B. Guo, D. R. Herbert, A. Bulfone, F. Trentini, et al. 2013. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19: 739-746.
9. Roncarolo, M. G., M. K. Levings, and C. Traversari. 2001. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193: F5-F9.
10. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
11. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166: 5530-5539.
12. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
13. + T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
14. Bergmann, C., L. Strauss, R. Zeidler, S. Lang, and T. L.Whiteside. 2007. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment. Cancer Immunol. Immunother. 56: 1429-1442.
15. H3 regulatory cells. Nat. Immunol. 2: 671-672.
16. Gregori, S., D. Tomasoni, V. Pacciani, M. Scirpoli, M. Battaglia, C. F. Magnani, E. Hauben, and M. G. Roncarolo. 2010. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116: 935-944.
17. Apetoh, L., F. J. Quintana, C. Pot, N. Joller, S. Xiao, D. Kumar, E. J. Burns, D. H. Sherr, H. L. Weiner, and V. K. Kuchroo. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11: 854-861.
18. + T cells via the phosphorylation of STAT1 and STAT3. Immunol. Lett. 136: 21-28.
19. Jin, J. O., X. Han, and Q. Yu. 2013. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J. Autoimmun. 40: 28-44.
20. Wakkach, A., F. Cottrez, and H. Groux. 2001. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. 167: 3107-3113.
21. Marie, J. C., A. L. Astier, P. Rivailler, C. Rabourdin-Combe, T. F. Wild, and B. Horvat. 2002. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3: 659-666.
22. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392.
23. L. J. Immunol. 185: 3785-3787.
24. Greenfield, E. A., K. A. Nguyen, and V. K. Kuchroo. 1998. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18: 389-418.
25. Kohlmeier, J. E., and S. H. Benedict. 2003. Alternate costimulatory molecules in T cell activation: differential mechanisms for directing the immune response. Histol. Histopathol. 18: 1195-1204.
26. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
27. Chen, Z., and J. J. O'Shea. 2008. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 41: 87-102.
28. Yashiro, Y., X. G. Tai, K. Toyo-oka, C. S. Park, R. Abe, T. Hamaoka, M. Kobayashi, S. Neben, and H. Fujiwara. 1998. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules. Eur. J. Immunol. 28: 926-935.
29. deWit, J., Y. Souwer, A. J. van Beelen, R. de Groot, F. J. Muller, H. Klaasse Bos, T. Jorritsma, M. L. Kapsenberg, E. C. de Jong, and S. M. van Ham. 2011. CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation. Blood 118: 6107-6114.
30. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7: 35-58.
31. Hamann, J., B. Vogel, G. M. van Schijndel, and R. A. van Lier. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184: 1185-1189.
32. Abbott, R. J., I. Spendlove, P. Roversi, H. Fitzgibbon, V. Knott, P. Teriete, J. M. McDonnell, P. A. Handford, and S. M. Lea. 2007. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J. Biol. Chem. 282: 22023-22032.
33. + T cells mediated by CD97. J. Immunol. 177: 1070-1077.
34. Spendlove, I., J. M. Ramage, R. Bradley, C. Harris, and L. G. Durrant. 2006. Complement decay accelerating factor (DAF)/CD55 in cancer. Cancer Immunol. Immunother. 55: 987-995.
35. Wing, K., Z. Fehérvári, and S. Sakaguchi. 2006. Emerging possibilities in the development and function of regulatory T cells. Int. Immunol. 18: 991-1000.
36. Cope, A., G. Le Friec, J. Cardone, and C. Kemper. 2011. The Th1 life cycle: molecular control of IFN-γ to IL-10 switching. Trends Immunol. 32: 278-286.
37. Kohlmeier, J. E., M. A. Chan, and S. H. Benedict. 2006. Costimulation of naive human CD4 T cells through intercellular adhesion molecule-1 promotes differentiation to a memory phenotype that is not strictly the result of multiple rounds of cell division. Immunology 118: 549-558.
38. Bour-Jordan, H., and J. A. Bluestone. 2009. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229: 41-66.
39. Gottschalk, R. A., E. Corse, and J. P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207: 1701-1711.
40. Semple, K., A. Nguyen, Y. Yu, H. Wang, C. Anasetti, and X. Z. Yu. 2011. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 117: 3096-3103.
41. Harris, C. L., R. J. Abbott, R. A. Smith, B. P. Morgan, and S. M. Lea. 2005. Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J. Biol. Chem. 280: 2569-2578.
42. Pot, C., H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai, R. Madan, A. H. Sharpe, C. L. Karp, S. C. Miaw, I. C. Ho, and V. K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183: 797-801.
43. + Tr cells. Blood 105: 1162-1169.
44. Wu, H. Y., F. J. Quintana, A. P. da Cunha, B. T. Dake, T. Koeglsperger, S. C. Starossom, and H. L. Weiner. 2011. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One 6: e23618.
45. Svensson, M., A. Maroof, M. Ato, and P. M. Kaye. 2004. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 21: 805-816.
46. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
47. Roncarolo, M. G., and S. Gregori. 2008. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 38: 925-927.
48. + effector T cells: a mechanism for self-regulation. Mucosal Immunol. 3: 239-246.
49. Zhu, J., and W. E. Paul. 2010. Heterogeneity and plasticity of T helper cells. Cell Res. 20: 4-12.
50. O'Shea, J. J., C. A. Hunter, and R. N. Germain. 2008. T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable? Nat. Immunol. 9: 450-453.
51. + T cells. Science 327: 1098-1102.
52. Naldi, A., J. Carneiro, C. Chaouiya, and D. Thieffry. 2010. Diversity and plasticity of Th cell types predicted from regulatory network modelling. PLOS Comput. Biol. 6: e1000912.